Clinical News: Page 1726

Shear-wave elastography improves breast US specificity
By Kate Madden Yee
Tuesday, November 27 | 5:00 p.m.-5:30 p.m. | LL-BRS-TU1C | Lakeside Learning CenterShear-wave elastography improves breast ultrasound's ability to distinguish benign from malignant solid breast nodules, according to a study by researchers from the University of Toronto.
November 13, 2012
'White wall' characteristic on ABUS indicates benign lesion
By Kate Madden Yee
Tuesday, November 27 | 3:40 p.m.-3:50 p.m. | SSJ01-05 | Arie Crown TheaterAn echogenic "white wall" in a hypoechoic lesion visualized on automated breast ultrasound (ABUS) suggests a benign lesion, and patients may not need to be recalled for further evaluation, according to researchers from George Washington University Medical Center.
November 13, 2012
ABUS boosts mammography's performance
By Kate Madden Yee
Tuesday, November 27 | 3:30 p.m.-3:40 p.m. | SSJ01-04 | Arie Crown TheaterWhat does automated breast ultrasound (ABUS) contribute to cancer screening when it's used with mammography in women with dense breasts? Researchers from the University of Chicago will present findings that address this question on Tuesday afternoon.
November 13, 2012
US-guided core-needle breast biopsy OK for preop staging
By Kate Madden Yee
Tuesday, November 27 | 3:20 p.m.-3:30 p.m. | SSJ01-03 | Arie Crown TheaterWhich is better for assessing metastasis in newly diagnosed breast cancer: fine-needle aspiration or core biopsy? It's an important question, according to Finnish researchers, as the presence of axillary metastasis is the most significant prognostic factor in invasive breast cancer.
November 13, 2012
Triple-negative breast cancer shows specific US characteristics
By Kate Madden Yee
Tuesday, November 27 | 3:10 p.m.-3:20 p.m. | SSJ01-02 | Arie Crown TheaterCertain ultrasound characteristics can help clinicians identify triple-negative breast cancer, researchers from Chile will report in this scientific session.
November 13, 2012
ABUS detects suspicious lesions found on breast MRI
By Kate Madden Yee
Tuesday, November 27 | 3:00 p.m.-3:10 p.m. | SSJ01-01 | Arie Crown TheaterAutomated breast ultrasound (ABUS) could prove helpful for evaluating additional suspicious lesions identified by breast MRI, and it's faster and more cost-effective than handheld second-look ultrasound, according to a study that will be presented on Tuesday afternoon.
November 13, 2012
Second reads for BI-RADS 3 lesions avoid misclassification
By Kate Madden Yee
Tuesday, November 27 | 11:40 a.m.-11:50 a.m. | SSG02-08 | Room E451AGetting a second read for BI-RADS 3 breast lesions at the time they are categorized can reduce interreader variability and, thus, misclassification, according to this study conducted by researchers at Boston University.
November 13, 2012
Breast MR more effective in identifying DCIS than BSGI
By Kate Madden Yee
Tuesday, November 27 | 11:40 a.m.-11:50 a.m. | SSG01-08 | Arie Crown TheaterMRI has higher sensitivity for detecting ductal carcinoma in situ (DCIS) and is more helpful than breast-specific gamma imaging (BSGI) in cases with no calcification on mammography, according to this Tuesday morning study conducted by Korean researchers.
November 13, 2012
Breast MRI tumor features may predict cancer recurrence
By Kate Madden Yee
Tuesday, November 27 | 11:20 a.m.-11:30 a.m. | SSG01-06 | Arie Crown TheaterBreast MRI tumor-specific interpretation features may have value in assessing breast cancer prognosis and aid in treatment decisions, University of Pennsylvania researchers will report in this Tuesday morning session.
November 13, 2012
Does practice site affect mammography recall rates?
By Kate Madden Yee
Tuesday, November 27 | 10:50 a.m.-11:00 a.m. | SSG02-03 | Room E451AMammography recall rates for individual readers can vary by site, which raises questions about the use of recall rates as a pay-for-performance measure, according to researchers from Brown University.
November 13, 2012
Low-dose MBI safe adjunct to screening mammo
By Kate Madden Yee
Tuesday, November 27 | 10:40 a.m.-10:50 a.m. | SSG01-02 | Arie Crown TheaterLow-dose molecular breast imaging (MBI) is a viable adjunct to screening mammography in women with dense breasts, according to Mayo Clinic researchers.
November 13, 2012
Adding DBT to mammography lowers recall rates
By Kate Madden Yee
Monday, November 26 | 3:30 p.m.-3:40 p.m. | SSE02-04 | Room E450AUsing digital breast tomosynthesis (DBT) as an adjunct to mammography lowers recall rates, according to this Monday afternoon scientific session.
November 13, 2012
Previous Page
Page 1726 of 3659
Next Page